Since immunotherapy through programmed cell death protein 1 (PD-1)/programmed cell death ligand 1 (PD-L1) blockade has shown benefits for gastric cancer, epigenetic DNA methylation critically modulates cancer immune checkpoints. This evidence concerns the gene PDCD1 and gastric cancer.